Effect of tamoxifen after chemotherapy in hormone receptor-positive, node-negative breast cancer

被引：0
|
作者：
Panasci, LC [1 ]
机构：
[1] Sir Mortimer B Davis Jewish Hosp, Montreal, PQ H3T 1E2, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 15期
关键词：
D O I：
10.1200/JCO.2006.05.7562
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2392 / 2392
页数：1
相关论文
共 50 条
  • [21] Efficacy of chemotherapy after hormone therapy for hormone receptor-positive metastatic breast cancer
    Mori, Ryutaro
    Nagao, Yasuko
    SAGE OPEN MEDICINE, 2014, 2
  • [22] Prognostic Value of a Positive-to-negative Change in Hormone Receptor Status after Neoadjuvant Chemotherapy in Patients with Hormone Receptor-positive Breast Cancer
    Chen, Sheng
    Chen, Can-Ming
    Yu, Ke-Da
    Zhou, Ruo-Ji
    Shao, Zhi-Ming
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (09) : 3002 - 3011
  • [23] Racial Differences in 21-Gene Recurrence Scores Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer
    Holowatyj, Andreana N.
    Cote, Michele L.
    Ruterbusch, Julie J.
    Ghanem, Kristina
    Schwartz, Ann G.
    Viguerm, Fawn D.
    Gorski, David H.
    Purrington, Kristen S.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (07) : 652 - +
  • [24] Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial
    Albain, Kathy S.
    Gray, Robert J.
    Makower, Della F.
    Faghih, Amir
    Hayes, Daniel F.
    Geyer, Charles E., Jr.
    Dees, Elizabeth C.
    Goetz, Matthew P.
    Olson, John A., Jr.
    Lively, Tracy
    Badve, Sunil S.
    Saphner, Thomas J.
    Wagner, Lynne, I
    Whelan, Timothy J.
    Ellis, Matthew J.
    Wood, William C.
    Keane, Maccon M.
    Gomez, Henry L.
    Reddy, Pavan S.
    Goggins, Timothy F.
    Mayer, Ingrid A.
    Brufsky, Adam M.
    Toppmeyer, Deborah L.
    Kaklamani, Virginia G.
    Berenberg, Jeffrey L.
    Abrams, Jeffrey
    Sledge, George W., Jr.
    Sparano, Joseph A.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (04): : 390 - 399
  • [25] Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer
    Foekens, John A.
    Sieuwerts, Anieta M.
    Smid, Marcel
    Look, Maxime P.
    de Weerd, Vanja
    Boersma, Antonius W. M.
    Klijn, Jan G. M.
    Wiemer, Erik A. C.
    Martens, John W. M.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (35) : 13021 - 13026
  • [26] NODE-NEGATIVE BREAST-CANCER - TAMOXIFEN AND CHEMOSUPPRESSION
    JORDAN, VC
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (12) : 1068 - 1069
  • [27] Tamoxifen resistance: EGFR expression in hormone receptor-positive and HER2 negative breast cancer
    Bae, S. Y.
    Nam, S. J.
    Lee, S. K.
    Kim, S. W.
    Lee, J. E.
    Yu, J. H.
    CANCER RESEARCH, 2017, 77
  • [28] Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence Scores
    Chen, Jonathan
    Wu, Xian
    Christos, Paul J.
    Formenti, Silvia
    Nagar, Himanshu
    BREAST CANCER RESEARCH, 2018, 20
  • [29] Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence Scores
    Jonathan Chen
    Xian Wu
    Paul J. Christos
    Silvia Formenti
    Himanshu Nagar
    Breast Cancer Research, 20
  • [30] Prognostic stratification of oestrogen receptor-positive HER2-negative lymph node-negative class of breast cancer
    Rakha, Emad A.
    Agarwal, Devika
    Green, Andrew R.
    Ashankyty, Ibraheem
    Ellis, Ian O.
    Ball, Graham
    Alaskandarany, Mohammed A.
    HISTOPATHOLOGY, 2017, 70 (04) : 622 - 631
12345